Senate clears way for von Eschenbach vote

Share this article:
The US Senate today voted to end debate on the nomination of Andrew von Eschenbach to permanently head the FDA, clearing the way for a final vote. Von Eschenbach supporters overcame objections from three Republican senators who opposed his nomination. In a procedural move, the Senate voted, 89-6, to end debate over the nomination. A Senate vote to confirm von Eschenbach as FDA commissioner was expected later today, Reuters reported. Von Eschenbach has served as acting FDA commissioner since September 2005. He was nominated earlier this year by President Bush to take the job permanently.
Share this article:

Email Newsletters

More in News

Doctors want to know how CMS plans to display Sunshine payment data

Doctors want to know how CMS plans to ...

Physician and industry trade groups are asking CMS to explain how context will be provided to the general public around the dollar sums drugmakers ascribe to doctors for things like ...

Pfizer Q2 sales slip, but still beat expectations

Pfizer Q2 sales slip, but still beat expectations

Patent losses and lost co-promotion agreements put a dent in sales.

Lack of marketing partner delays Afrezza launch

Lack of marketing partner delays Afrezza launch

Afrezza was heralded as one of the most innovative diabetes products of the last decade. So, why hasn't MannKind set a firm launch date for the product?